Preclinical candidates for CNS penetrant (Aeovian Pharmaceuticals)

N/A

Report date: 2024/09/18 10:42:16
NME

Base Information

Drug NamePreclinical candidates for CNS penetrant (Aeovian Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitors
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAeovian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeovian Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A